Furthermore, through GO and KEGG analysis, we discovered that the genes downregulated after MZ1 treatment are extensively involved in cell mitosis, cell cycle processes, and the PI3K-AKT signaling pathway, providing initial insights into the anti-tumor mechanisms of MZ1 (Fig. 6c, d). The gene discussed is AKT1; the disease is neoplasm.